Effective ownership transition planning is critical for private medical groups to ensure continuity, fair value realization for retiring physicians, and smooth entry for new physician-owners. Well-designed legal and financial frameworks, such as buy-sell agreements and structured buy-in/buy-out plans, enable physicians to buy into and exit practice ownership gradually. This life-cycle approach (from initial partnership buy-ins to eventual retirements) helps align ownership stakes with each physician's career stage, encouraging senior doctors to sell portions of equity as they approach retirement and allowing younger doctors to invest in the practice at a manageable pace. Below we outline key strategies, structures, and real-world examples for ongoing ownership transitions in U.S. private practices, focusing on internal succession (physician-to-physician transitions). A comparison table summarizes different transition models, with features, pros, and cons, followed by a discussion on valuing buyouts (including the influence of private equity valuations) and illustrative case studies.
Core Framework: Legal and Financial Structures for Ownership Transitions
Buy-Sell Agreements
A buy-sell (shareholder) agreement is the cornerstone of any practice's ownership transition plan. This legally binding document (often part of the partnership agreement) lays out when and how ownership interests can be bought or sold. Key elements include:
Triggering Events
Define events that initiate ownership transitions (e.g., planned retirement, death, disability or a physician's departure). For example, the agreement may require a physician reaching a certain age or retirement timeline to offer their shares to remaining partners or the practice. This ensures an orderly, pre-planned exit even if a senior partner might otherwise hold onto shares too long.
Valuation Method
Establish a clear method to price the shares. Common methods include:
- Book Value / Asset-Based Valuation: Valuing tangible assets (equipment, furniture, accounts receivable) often forms the base price for shares.
- Goodwill or Intangible Value: Defining how to value the practice's intangible assets (goodwill). Some agreements use external appraisals or industry benchmarks (e.g., the Goodwill Registry) to add a goodwill component[1], while others use simplified formulas (e.g., a multiple of average earnings). Many practices avoid contentious goodwill debates by limiting buy-in price to tangible assets or using income adjustment methods instead of a large upfront payment for goodwill.
- Fixed Formulas vs. Periodic Appraisals: Decide whether to update valuations with each transaction via a fresh appraisal or to use a fixed formula that's periodically recalibrated. Formal third-party valuations ensure fairness but can be costly; simpler formulas (like a revenue multiple or a set dollar amount per partner) are easier but might not capture market value.
Funding and Payment Terms
Outline how a buy-in or buy-out will be financed:
- Installment Payments (Promissory Notes): Instead of a lump sum, the purchasing physician pays over several years. For example, a retiring doctor might sell their stake in exchange for a 5-year promissory note, providing the retiree steady income while the junior partner pays gradually from practice earnings.
- Income Adjustment ("Sweat Equity"): New partners effectively "pay" for their shares by taking a temporarily reduced compensation. For instance, a new partner might start at 60% of full profit share in year 1, 70% in year 2, etc., with the senior partners receiving the difference. Over a few years, the new physician reaches full parity, having bought in via forgone income rather than debt.
- Practice-Financed Buy-Outs: The practice itself can buy back a departing owner's shares (often using the practice's cash or bank loans) and then redistribute or resell those shares to others. Buy-out payments to the departing doctor are commonly spread over 2–5 years as deferred compensation from future profits, easing the financial hit on the practice and often yielding tax benefits (deductible to the practice; ordinary income to the seller).
- Insurance for Contingencies: Life or disability insurance policies on partners can fund buy-outs if a physician dies or becomes disabled unexpectedly. The insurance payout buys the departed physician's shares (at a pre-agreed price) so that their estate is compensated and the practice isn't financially strained.
Governance and Control During Transitions
The agreement should address how decision-making evolves as ownership shifts. Some groups decouple ownership percentage from control by requiring super-majority votes for major decisions, ensuring that senior doctors can sell shares without losing disproportionate control immediately. Clear provisions (e.g. board composition, voting rights after partial buy-outs, call options for the practice to force a buy-out at a certain age) maintain stability and prevent stalemates as ownership changes.
Valuation and Equity Distribution Models
Crafting the buy-sell terms involves agreeing on how practice value is calculated and how ownership slices adjust over time:
Tangible vs. Intangible Value Policies
Goodwill (practice reputation, patient loyalty, brand) is often the toughest piece to handle. Some practices choose to exclude goodwill from the buy-in price to keep it affordable for new partners, essentially "giving" the practice's intangible value to them. Others charge for goodwill but might offer a discount or allow it to be paid over time. Excluding or heavily discounting goodwill lowers the barrier for partnership (vital for recruitment when younger doctors carry debt), but it means senior doctors don't fully cash out the practice's intangible value unless they negotiate another way (such as a separate retirement bonus or larger share of ongoing profits). Including goodwill ensures new owners have skin in the game for the practice's full value, but the higher price can be prohibitive. There's no one-size-fits-all answer; many groups strike a balance by, say, low upfront buy-in costs (to attract new partners) and a formula-driven goodwill payout upon retirement (to reward founders for building the practice).
Equal vs. Variable Ownership Shares
Traditional practices often default to equal equity shares once partners buy in. Increasingly, groups allow non-equal ownership to reflect differing tenure or investment:
- Some practices establish a tiered partnership (e.g. junior partners start at a smaller equity percentage with lower buy-in cost, which increases after additional years or capital contributions).
- Senior partners nearing retirement might intentionally hold a smaller stake than mid-career partners. For example, a 65-year-old physician could sell portions of ownership to colleagues such that by retirement, they maybe own only 10% (down from, say, 25%), ensuring younger doctors have larger stakes and a deeper commitment before the senior fully exits.
- These arrangements must be paired with compensation plans that remain perceived as fair. Profit distributions might track ownership, but some groups use productivity-based bonuses or pooled revenue-sharing to reward work effort regardless of minor equity differences[2]. The key is transparency so that all partners understand how equity and income interplay, avoiding resentment.
Periodic Revaluations vs. Fixed Entry Price
An internal question is whether each new partner pays the same buy-in price (e.g. a fixed amount used historically, like $X for a 1/N share) or if that price is updated with practice growth. Many practices opt for valuations at each transaction to keep prices current, but this can mean later partners pay more than earlier ones (which might seem inequitable). Fixed prices are simpler and seen as a perk for early joiners, but risk undervaluing the practice over time. Hybrid approaches exist, such as capping the buy-in price to a multiple of the initial price or limiting increases to inflation. The approach should fit the group's philosophy on fairness vs. reward for growth.
Private Equity vs. Internal Sale: The Valuation Gap
A significant challenge in succession planning is the disparity between internal valuations and what external buyers (e.g. private equity firms) might pay for the practice. Private equity groups often base purchase offers on a multiple of the practice's Trailing Twelve Months (TTM) Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization)[3]. For desirable specialties and larger practices, these multiples can be substantially higher than what an internal buyout would involve. For instance, by late 2025, OB/Gyn and women's health practices were reportedly trading around 10×–14× EBITDA for large "platform" acquisitions, versus ~5×–8× for smaller add-on deals[4]. More generally, even a solid mid-sized practice with $1–3M in EBITDA might command 7×–9× EBITDA in a competitive sale[5], translating to a hefty purchase price. This means a practice netting $2M in adjusted annual EBITDA could fetch on the order of $14–18 million from a private equity buyer. By contrast, internal succession plans often do not value the practice at such high multiples, since the goal is fairness and affordability for incoming physicians[6]. An internal buy-in is frequently based on tangible assets plus perhaps a modest goodwill component (similar to hospital acquisitions that exclude paying for goodwill entirely)[7].
The result is a potential misalignment: senior physicians nearing retirement see the much higher valuations external buyers offer (with private equity deals commonly including a mix of upfront cash and equity roll-over in the new entity) and may feel selling the practice externally is financially more attractive[8] [9]. They might be reluctant to sell shares internally for a lower price, especially if the gap is several million dollars. Meanwhile, younger doctors value preserving the practice's independence and culture and may not favor an outside sale, especially if they're committed to a career in the practice beyond the seniors' tenure[10].
Managing this tension requires transparent dialogue among partners about priorities and creative solutions to bridge the value gap. Some best practices include: (1) Benchmarking valuations, periodically inform all partners of the practice's estimated market value (e.g. via external appraisal) so that internal buyout discussions are grounded in reality; (2) Incentive alignment, if internal buyouts are at a discount to market value, consider sweeteners like post-retirement consulting fees or a deferred bonus to retiring doctors tied to the practice's post-transition performance, as a way to acknowledge the "sacrifice" of selling internally for less; (3) Right-of-first-refusal clauses, some agreements stipulate that if an external offer exceeds the internal valuation by a certain amount, the group will formally reconsider a sale or adjust internal pricing. Ultimately, each group must balance immediate financial upside vs. long-term autonomy. Many physician-owners who choose internal succession do so because they prioritize preserving the practice's legacy, team, and clinical autonomy over maximizing sale price[11] [12]. Others, especially if no junior partners are ready or willing to buy in, may opt for the high EBITDA multiple payout of a third-party sale as part of their retirement strategy. It's crucial to acknowledge these factors in the buyout plan so that all partners remain on the same page.
Strategies for Ongoing Ownership Transitions
Private practices typically use one or a combination of the following transition models to allow physicians to enter and exit partnerships smoothly. Each model has advantages and drawbacks, and many practices tailor a hybrid approach to suit their size, specialty, and goals. Table 1 compares common internal transition models (with a note on external sale for context), followed by real-world examples.
Best Practices to Encourage Early Partial Buy-Outs
One common scenario in group practices is an age gap between partners, for example, one senior physician might be a decade older than the next-oldest. In such cases, it's often beneficial for the senior doctor to gradually reduce their ownership stake as retirement nears, allowing younger partners to step up. However, convincing a senior physician to sell a larger portion of ownership earlier can be challenging if they fear losing income or control. Here are best practices to align incentives and facilitate these life-cycle adjustments:
Incentivize Early Transition via Agreements
As noted above, a robust buy-sell agreement can include provisions that trigger partial buy-outs at predetermined ages or timelines. For instance, the agreement might specify that at age 60, a physician will offer, say, 10% of their shares to the junior partners (or back to the practice) for purchase. By hardwiring the expectation, it normalizes the idea that the oldest partner will not remain the top shareholder indefinitely. Some agreements tie this to recruitment of new doctors: e.g., when a new partner is admitted, each existing partner over a certain age must sell a fixed percentage of shares to make room for the newcomer. This ensures proportional ownership shifts from older to younger over time.
Valuation Discounts or Credits
To encourage a hesitant senior physician, the practice might offer a slight pricing premium for early sell-downs. For example, if the standard valuation for internal sales is $100 per share, the practice could agree to pay $110 per share for any ownership sold more than five years prior to the expected retirement. This rewards the senior doctor for proactive transition and can make them more willing to part with shares sooner. Conversely, some groups use a mild penalty for delay, reducing the payout multiple for those who wait too long to sell (unless market conditions justify it). The goal is to align the physician's financial interest with the timing that benefits the practice's continuity.
Flexible Roles for Semi-Retired Physicians
Many senior doctors worry that selling ownership means an abrupt end to their career or influence. By creating pathways for phased retirement, you remove this barrier. For example, a doctor could sell 50% of their stake but stay on in a reduced schedule, focusing on clinical work or mentorship while younger partners assume leadership roles. They might become "of counsel" or take a Medical Director title, advising on quality or training. This lets them retain a connection and some income (through salary or a smaller profit share) even as they free up capital by selling shares. In one case, a solo practitioner executed such a plan: gradually selling the practice to an associate over 5 years, then staying part-time as an employed physician for two additional years. The senior doctor secured retirement funds and a graceful exit; the junior gained ownership and an experienced mentor.
Open Communication and Shared Vision
Addressing an older physician's hesitancy often comes down to aligning on the practice's mission and legacy. If the person has spent decades building the practice, they might be more receptive to internal succession if they believe the younger doctors share their commitment to that legacy. Regular frank discussions about retirement goals, the future of the practice, and how each partner's contributions will be honored can build trust. Some groups create a succession committee years in advance, including both senior and junior members, to plan leadership transition and address concerns openly. When senior physicians feel assured that their life's work will be in good hands (and that they'll be respected in the process), they're more likely to reduce their stake as needed.
Model Financial Scenarios
Sometimes seeing the financial projections can alleviate fear. Utilize a financial model to show the senior doctor how a phased sell-down impacts their overall wealth and retirement income. Often, even selling a portion now and investing those proceeds, while retaining some ownership until final retirement, can be as or more financially secure than holding all equity until the end (especially considering the risk of unforeseen events). If the practice brings in a new partner who increases overall earnings, the pie grows, which can compensate for having a smaller slice. Demonstrating that "1% of a larger practice might be worth as much as 2% of a smaller practice" can help the older physician see upside in empowering growth through ownership expansion.
Real-World Examples of Transition Models
Case Study 1: Gradual Buy-Out of a Solo Practice
A solo internal medicine practitioner in her late 50s wanted to retire in about 5 years but had no partners. She identified a younger physician (early 40s) to take over. They crafted a plan where the junior doctor bought in 20% each year over 5 years. They signed a buy-sell agreement locking in a valuation formula based on tangible assets and a modest goodwill figure. Payments were via a promissory note with monthly installments backed by practice revenues. The senior doctor also reduced her schedule over time: in Year 1–3 she worked 3 days/week (with the junior covering the rest), and in Years 4–5 she shifted to purely consulting and administrative duties. By the end of Year 5, the junior physician owned 100%. The senior had effectively sold the practice at a pace the junior could afford, receiving steady income plus the satisfaction of seeing her patients' care smoothly handed off. The junior doctor was fully integrated by the final transition and the practice retained nearly all patients and staff throughout.
Case Study 2: Multi-Partner Group, Structured Partial Buy-Ins
A radiology group in the Midwest had 8 equal partners, two of whom were planning to slow down within 3 years. To avoid a cash crunch from back-to-back retirements, they instituted a policy: beginning 3 years before a partner's expected retirement, that partner's ownership would be incrementally redistributed to others. In practice, when Dr. A turned 62, the buy-sell agreement triggered a 10% sale of Dr. A's shares to the remaining partners. Each of the younger 7 partners purchased roughly 1.4% (so Dr. A went from ~12.5% to ~2.5% ownership over 3 years). The price was set by an annual third-party valuation and funded by each buyer's share of practice profits (essentially a withheld portion of distributions). Dr. A's income from practice operations dropped as shares were sold, but this was offset by the proceeds from selling shares and working fewer nights. Three years later, Dr. A fully retired, and the final 2.5% was bought out by the practice via a 2-year note. A year after Dr. A's start of sell-down, the next senior partner, Dr. B, began the same process. This staggering ensured the practice wasn't hit with multiple large payouts at once. Outcome: Over 5 years, two senior radiologists transitioned out, four junior radiologists became new partners (each getting a slice of equity from the seniors' sales), and the practice remained physician-owned without any external sale. The orderly hand-off also signaled younger doctors that partnership opportunities would open in a predictable way, aiding retention.
Case Study 3: Private Equity Acquisition vs. Internal Succession, a Fork in the Road
A profitable dermatology practice in Florida with three senior dermatologists (all in their late 50s) and two younger associates faced a choice. The senior partners had an offer from a private equity-backed dermatology platform valuing the practice at 7× EBITDA, implying a multi-million dollar buyout for each. However, the associates were promising and interested in partnership. With guidance from a consultant, the group ran two scenarios: an external sale vs. an internal buyout. In the external sale scenario, the seniors would sell 80% of their ownership, receive mostly cash plus some equity in the larger platform, and the associates would become employees (with possible bonuses but no equity). In the internal succession scenario, the practice would instead use an income-splitting buy-in: each associate could purchase, over 3 years, a 15% stake from the seniors by taking a 25% reduction in their income (the withheld amount going to the seniors). The seniors would also be paid a separate 5-year retirement stipend after fully retiring, funded by the practice (partly to compensate for not capturing full market value). After extensive discussion, the group chose the internal succession path: the seniors valued the legacy of their independent practice and their relationships with staff. They proceeded with the phased sell-down; within 3 years, the associates became partners (each with ~30% ownership). All three senior dermatologists retired on schedule at age 60–62, receiving their scheduled payouts. Five years later, the two remaining partners (formerly associates) have since recruited a new dermatologist who is starting the buy-in process. The practice continues to thrive, now under second-generation ownership, and plans call for eventually expanding to new locations, something that may not have been possible had they sold to the PE-backed entity.
